JP2006514097A - 細胞生育促進方法 - Google Patents

細胞生育促進方法 Download PDF

Info

Publication number
JP2006514097A
JP2006514097A JP2004571396A JP2004571396A JP2006514097A JP 2006514097 A JP2006514097 A JP 2006514097A JP 2004571396 A JP2004571396 A JP 2004571396A JP 2004571396 A JP2004571396 A JP 2004571396A JP 2006514097 A JP2006514097 A JP 2006514097A
Authority
JP
Japan
Prior art keywords
subject
treating
cell population
compound
transplant cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004571396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514097A5 (https=
Inventor
ジェイ． スティア，クリフォード
シー． ロウ，ウォルター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
Original Assignee
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota System filed Critical University of Minnesota System
Publication of JP2006514097A publication Critical patent/JP2006514097A/ja
Publication of JP2006514097A5 publication Critical patent/JP2006514097A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
JP2004571396A 2003-04-02 2003-04-02 細胞生育促進方法 Pending JP2006514097A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/009819 WO2004096123A2 (en) 2003-04-02 2003-04-02 Methods of promoting cell viability

Publications (2)

Publication Number Publication Date
JP2006514097A true JP2006514097A (ja) 2006-04-27
JP2006514097A5 JP2006514097A5 (https=) 2006-06-15

Family

ID=33415179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004571396A Pending JP2006514097A (ja) 2003-04-02 2003-04-02 細胞生育促進方法

Country Status (5)

Country Link
EP (1) EP1615497A2 (https=)
JP (1) JP2006514097A (https=)
CN (1) CN1770975A (https=)
AU (1) AU2003230767A1 (https=)
WO (1) WO2004096123A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
WO2006026555A2 (en) * 2004-08-30 2006-03-09 Seo Hong Yoo Neuroprotective effect of solubilized udca in focal ischemic model
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
WO2014036379A2 (en) * 2012-08-31 2014-03-06 Metselex Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
US9872865B2 (en) 2013-03-24 2018-01-23 Amylyx Pharmaceuticals Inc. Compositions for improving cell viability and methods of use thereof
LT3016654T (lt) * 2013-07-01 2018-11-12 Bruschettini S.R.L. Tauroursodeoksicholio rūgštis (tudca), skirta panaudoti neurodegeneracinių susirgimų gydymui
CN109628379A (zh) * 2018-12-18 2019-04-16 西安交通大学 一种动物克隆胚胎培养液及培养方法
US11583542B2 (en) 2019-12-16 2023-02-21 Amylyx Pharmaceuticals, Inc. Compositions of bile acids and phenylbutyrate compounds
CN116262121A (zh) * 2021-12-15 2023-06-16 南湖实验室 牛磺熊去氧胆酸及其钠盐在抗衰老和/或延长寿命中的应用
US12138272B2 (en) 2022-05-12 2024-11-12 Amylyx Pharmaceuticals, Inc. Methods and compositions for treating amyotrophic lateral sclerosis

Also Published As

Publication number Publication date
CN1770975A (zh) 2006-05-10
WO2004096123A3 (en) 2005-04-14
WO2004096123A2 (en) 2004-11-11
AU2003230767A1 (en) 2004-11-23
AU2003230767A8 (en) 2004-11-23
EP1615497A2 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
WO2014036377A1 (en) Methods of promoting cell viability
Duan et al. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease
EP2446892B1 (de) Isolierte adulte pluripotente Stammzellen
Galpern et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology
US6713245B2 (en) Methods for storing neural cells such that they are suitable for transplantation
Kanaan et al. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease
Sinclair et al. Dopamine cells in nigral grafts differentiate prior to implantation
JP2006514097A (ja) 細胞生育促進方法
WO2021223346A1 (zh) 山药蛋白提取物在制备治疗勃起功能障碍的药物中的应用
Abdanipour et al. Intraspinal transplantation of motoneuron-like cell combined with delivery of polymer-based glial cell line-derived neurotrophic factor for repair of spinal cord contusion injury
Mazen et al. Therapeutic role of adipose tissue–derived stem cells versus microvesicles in a rat model of cerebellar injury
US20060204481A1 (en) Methods of promoting cell viability
RU2477637C2 (ru) Способ лечения острого нарушения мозгового кровообращения ишемического и геморрагического характера
US12440500B2 (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
KR20180115209A (ko) 불임증의 처치에 사용되는 의약 조성물 및 그 제조 방법
JP7762915B2 (ja) 運動ニューロン疾患（ｍｎｄ）の治療に有効な多能性幹細胞
Boeve et al. Early morphogenesis of the canine lens, hyaloid system, and vitreous body
CN108938631B (zh) Sag在制备治疗发育期缺氧缺血脑损伤疾病的药物中的应用
Peruffo et al. Primary cultures from fetal bovine brain
KR20050115945A (ko) 세포 생존율 증진 방법
CN119235921B (zh) 一种治疗与脂肪变性相关疾病的细胞治疗药物
JP7257012B1 (ja) 卵子成熟促進剤及びその用途
US12239668B2 (en) Pharmaceutical composition comprising periodontal tissue-derived pluripotent stem cells for prevention or treatment of male infertility
LU508143B1 (en) Application of Salidroside Pretreated Mesenchymal Stem Cells in Repairing Ischemic Brain Injury
RU2820936C2 (ru) Фитоэкдизоны и их производные для применения в лечении нервно-мышечных заболеваний

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060403

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060403

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090929

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100309